Drew Moghanaki, MD, FASTRO, MPH
Dr. Drew Moghanaki is Professor, Chief of Thoracic Oncology, and the Endowed Chair in Thoracic Radiation Oncology Research at the UCLA Department of Radiation Oncology. He holds a separate appointment at the United States Veterans Health Administration, where he leads over $60 million in lung cancer early detection and clinical trial initiatives. He previously led the largest lung cancer screening program in the Veterans Affairs: the “VA Partnership to Increase Access to Lung Screening”. He is co-chair of the Phase III randomized clinical trial evaluating stereotactic radiation therapy instead of surgery for operable stage I lung cancer, titled “VALOR”. Dr. Moghanaki is a steering committee member for the American Cancer Society National Lung Cancer Roundtable and serves on the scientific advisory boards of the LUNGevity Foundation, GO2 Foundation for Lung Cancer, and Lung Cancer Foundation of America.
Disclosures:
- Employment: David Geffen School of Medicine:Professor:Employee;Veterans Health Administration:Staff Physician:Employee
- Compensation: AstraZeneca: Education Meeting Faculty, Honoraria, Travel Expenses-End Date: Present ;Delfi Diagnostics: Consultant, Compensation Payment-End Date: Present ;Varian Medical Systems: Education Meeting Faculty, Travel Expenses, Compensation Payment-End Date: Present
- Ownership: LungLife AI:Stock Options
- Leadership: LungLife AI:Scientific Advisory Board Member